University Health System researchers discovered they could prevent diabetes from recurring in diabetic mice by transplanting insulin-manufacturing islet cells and then administering an anti-inflammatory drug called Lisofylline, according to a University Health System press release.
Researchers knew that transplantation was promising in treating type 1 diabetes. But the body destroyed islet cells without immune system-suppressing drugs.
The newly-created drug Lisofylline prevents cell destruction without the need for immune suppressants.
Researchers said their next step will be to test the drug in humans who have received islet cell transplants.
Read More
Virginia General Assembly demands answers about Ryan's resignation in Aug. 1 letter
By Brendon Bordwine | 4 minutes agoIn a 10-page letter obtained by The Cavalier Daily, State Sen. Creigh Deeds, D-Charlottesville, demanded written responses and documentation from University Rector Rachel Sheridan and University Vice Rector Porter Wilkinson regarding the lead up to and fallout from former University President Jim Ryan's resignation.
Weighing their place in U.Va. presidential search, students hope for leader with integrity
By Mia Tan | 2 days agoWith the search for the University’s 10th president underway, students are voicing cautious hopes for a leader who will prioritize transparency, integrity and the needs of the University community
Honor Committee discusses potential changes to its sanctioning process
By Bertie Azqueta | 3 days agoAny changes to the role of counsel could significantly affect how sanctioning is pursued by the reporter and the University community against those who committed Honor offenses.
